Consalvi, Silvia
 Distribuzione geografica
Continente #
EU - Europa 43
Totale 43
Nazione #
EE - Estonia 31
IT - Italia 12
Totale 43
Città #
Tallinn 31
Rome 11
Milan 1
Totale 43
Nome #
Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy 33
Advanced Methods to Study the Cross Talk Between Fibro-Adipogenic Progenitors and Muscle Stem Cells 4
HDAC4 is necessary for satellite cell differentiation and muscle regeneration 3
Epigenetic Reprogramming of Muscle Progenitors: Inspiration for Clinical Therapies 2
Synthesis of Novel Hyaluronic Acid Sulfonated Hydrogels Using Safe Reactants: A Chemical and Biological Characterization 2
Epigenetic tuning of miR in FAP-derived Extracellular Vesicles promotes regeneration and inhibits fibrosis in dystrophic muscles 1
Functional Cross-Talk Between the Different Cell Populations that Contribute to DMD Progression 1
HDAC inhibitors tune miRNAs in extracellular vesicles of dystrophic muscle-resident mesenchymalcells 1
Determinants of epigenetic resistance to HDAC inhibitors in dystrophic fibro-adipogenic progenitors. 1
Fibroadipogenic progenitor-derived exosomes for regeneration of dystrophic muscles 1
miR-143 is Activated Under TSA Conditions and Helps Cells to Choose an Anti-Adipogenic Fate 1
HDAC inhibitors tune miRNAs in extracellular vesicles of dystrophic muscle-resident mesenchymal cells 1
Epigenetic and transcriptomic profiling of primary muscle cells during DMD progression and HDACi treatment 1
HDAC4 regulates satellite cell proliferation and differentiation by targeting P21 and Sharp1 genes 1
Givinostat effects on DMD pathogenesis. 1
Endocannabinoid CB1 receptor is a target for PAX7 in satellite cells and implicated in Duchenne Muscular Dystrophy 1
Totale 55
Categoria #
all - tutte 89
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20248 0 0 0 0 0 0 0 0 0 0 0 8
2024/202547 1 0 14 31 1 0 0 0 0 0 0 0
Totale 55